Literature DB >> 7035298

Treatment of hepatic encephalopathy with metronidazole.

M H Morgan, A E Read, D C Speller.   

Abstract

Neomycin, an antibiotic which is primarily active against the aerobic gut flora and hence reduces the endogenous production of ammonia, is a well-recognised form of treatment for acute or acute on chronic hepatic encephalopathy. This study suggests that metronidazole may be a useful alternative or even adjunctive treatment for such patients. Theoretical and practical justifications for the use of this drug are presented. The results of a week's prescription of each drug have been assessed by changes in clinical and biochemical criteria, including electroencephalograms and arterial ammonia sample. In the treatment of a series of 11 mildly or moderately, and seven severely affected, patients with histologically confirmed cirrhosis, metronidazole is shown to be as effective as neomycin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7035298      PMCID: PMC1419597          DOI: 10.1136/gut.23.1.1

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  22 in total

1.  TREATMENT OF VINCENT'S STOMATITIS WITH METRONIDAZOLE.

Authors:  A H DAVIES; J A MCFADZEAN; S SQUIRES
Journal:  Br Med J       Date:  1964-05-02

2.  Asterixis in non-hepatic disorders.

Authors:  H O CONN
Journal:  Am J Med       Date:  1960-10       Impact factor: 4.965

3.  Methionine toxicity in liver disease and its prevention by chlortetracycline.

Authors:  E A PHEAR; B RUEBNER; S SHERLOCK; W H SUMMERSKILL
Journal:  Clin Sci       Date:  1956-02       Impact factor: 6.124

4.  The syndrome of impending hepatic coma in patients with cirrhosis of the liver given certain nitrogenous substances.

Authors:  G B PHILLIPS; R SCHWARTZ; G J GABUZDA; C S DAVIDSON
Journal:  N Engl J Med       Date:  1952-08-14       Impact factor: 91.245

5.  Activity of metronidazole against Escherichia coli in experimental intra-abdominal sepsis.

Authors:  A B Onderdonk; T J Louie; F P Tally; J G Bartlett
Journal:  J Antimicrob Chemother       Date:  1979-03       Impact factor: 5.790

6.  Bacterial ureases in uraemic men.

Authors:  C L Brown; M J Hill; P Richards
Journal:  Lancet       Date:  1971-08-21       Impact factor: 79.321

7.  Encephalopathy after portacaval anastomosis.

Authors:  A E Read; C F McCarthy; A B Ajdukiewicz; G J Brown
Journal:  Lancet       Date:  1968-11-09       Impact factor: 79.321

8.  Lactulose in the treatment of acute hepatic encephalopathy.

Authors:  J M Fessel; H O Conn
Journal:  Am J Med Sci       Date:  1973-08       Impact factor: 2.378

9.  Influence of neomycin and metronidazole on colonic microflora of volunteers.

Authors:  Y Arabi; F Dimock; D W Burdon; J Alexander-Williams; M R Keighley
Journal:  J Antimicrob Chemother       Date:  1979-09       Impact factor: 5.790

10.  Role of intestinal microflora in colonic pseudoobstruction complicating jejunoileal bypass.

Authors:  R E Barry; A W Chow; J Billesdon
Journal:  Gut       Date:  1977-05       Impact factor: 23.059

View more
  32 in total

Review 1.  Hepatic encephalopathy in liver cirrhosis: pathogenesis, diagnosis and management.

Authors:  T Gerber; H Schomerus
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

2.  Reduced stents and stent-grafts for the management of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation.

Authors:  David C Madoff; Michael J Wallace
Journal:  Semin Intervent Radiol       Date:  2005-12       Impact factor: 1.513

3.  Successful use of vancomycin hydrochloride in the treatment of lactulose resistant chronic hepatic encephalopathy.

Authors:  K Tarao; T Ikeda; K Hayashi; A Sakurai; T Okada; T Ito; H Karube; T Nomoto; T Mizuno; K Shindo
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

Review 4.  Rifaximin vs. conventional oral therapy for hepatic encephalopathy: a meta-analysis.

Authors:  Karim M Eltawil; Marie Laryea; Kevork Peltekian; Michele Molinari
Journal:  World J Gastroenterol       Date:  2012-02-28       Impact factor: 5.742

Review 5.  Pathophysiology, diagnosis, and management of hepatic encephalopathy.

Authors:  Christopher Sheasgreen; Lucy Lu; Ameen Patel
Journal:  Inflammopharmacology       Date:  2014-10-10       Impact factor: 4.473

Review 6.  Management of hepatic encephalopathy in the hospital.

Authors:  Michael D Leise; John J Poterucha; Patrick S Kamath; W Ray Kim
Journal:  Mayo Clin Proc       Date:  2014-01-08       Impact factor: 7.616

Review 7.  Pathogenesis, diagnosis, and treatment of hepatic encephalopathy.

Authors:  Dileep K Atluri; Ravi Prakash; Kevin D Mullen
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

Review 8.  Antibiotics for the treatment of hepatic encephalopathy.

Authors:  Kavish R Patidar; Jasmohan S Bajaj
Journal:  Metab Brain Dis       Date:  2013-02-08       Impact factor: 3.584

9.  Disposition of oral metronidazole in hepatic cirrhosis and in hepatosplenic schistosomiasis.

Authors:  T K Daneshmend; M Homeida; C M Kaye; A A Elamin; C J Roberts
Journal:  Gut       Date:  1982-10       Impact factor: 23.059

10.  Current trends in the treatment of hepatic encephalopathy.

Authors:  Mohamad Rasm Al Sibae; Brendan M McGuire
Journal:  Ther Clin Risk Manag       Date:  2009-08-03       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.